BCA
TWST icon

Berman Capital Advisors’s Twist Bioscience TWST Stock Holding History

Berman Capital Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$4K Buy
41
+25
+156% +$2.86K ﹤0.01% 1515
2021
Q2 		$2K Sell
16
-75
-82% -$8.72K ﹤0.01% 1642
2021
Q1 		$11K Buy
91
+88
+2,933% +$13.4K ﹤0.01% 1011
2020
Q4 		$0 Buy
+3
New +$333 ﹤0.01% 1830

Other funds holding TWST

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Berman Capital Advisors's TWST Position: Q3 2021 in Review

Berman Capital Advisors increased its Twist Bioscience (TWST) stake by 156% in Q3 2021, buying an estimated $2.86K and bringing the position to 41 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

Berman Capital Advisors first reported a position in TWST in Q4 2020 and has held it in 4 quarters since. The position peaked at $11K in Q1 2021. 236 funds tracked by Wall St. Rank hold TWST as of Q3 2021.

  • Berman Capital Advisors held 41 shares of Twist Bioscience worth $4K as of Q3 2021.
  • Berman Capital Advisors bought 25 Twist Bioscience shares in Q3 2021, an estimated $2.86K.
  • Twist Bioscience made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #1515 holding.
  • Berman Capital Advisors first reported a position in Twist Bioscience in Q4 2020 and has held it in 4 quarters since.
  • Berman Capital Advisors's Twist Bioscience position peaked at $11K in Q1 2021.
  • 236 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.